- Home
- STRO vs SQNS Comparison
STRO vs SQNS Comparison
Compare STRO & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- SQNS
- Stock Information
- Founded
- STRO 2003
- SQNS 2003
- Country
- STRO United States
- SQNS France
- Employees
- STRO N/A
- SQNS N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- SQNS Semiconductors
- Sector
- STRO Health Care
- SQNS Technology
- Exchange
- STRO Nasdaq
- SQNS Nasdaq
- Market Cap
- STRO 50.0M
- SQNS 48.3M
- IPO Year
- STRO 2018
- SQNS 2011
- Fundamental
- Price
- STRO $0.87
- SQNS $1.56
- Analyst Decision
- STRO Hold
- SQNS Strong Buy
- Analyst Count
- STRO 8
- SQNS 1
- Target Price
- STRO $6.14
- SQNS $7.50
- AVG Volume (30 Days)
- STRO 2.3M
- SQNS 95.1K
- Earning Date
- STRO 05-08-2025
- SQNS 05-06-2025
- Dividend Yield
- STRO N/A
- SQNS N/A
- EPS Growth
- STRO N/A
- SQNS N/A
- EPS
- STRO N/A
- SQNS 2.16
- Revenue
- STRO $62,043,000.00
- SQNS $38,858,000.00
- Revenue This Year
- STRO N/A
- SQNS N/A
- Revenue Next Year
- STRO $1.29
- SQNS $95.51
- P/E Ratio
- STRO N/A
- SQNS $0.70
- Revenue Growth
- STRO N/A
- SQNS 40.06
- 52 Week Low
- STRO $0.52
- SQNS $0.95
- 52 Week High
- STRO $5.17
- SQNS $4.28
- Technical
- Relative Strength Index (RSI)
- STRO 48.53
- SQNS 32.65
- Support Level
- STRO $0.80
- SQNS $1.38
- Resistance Level
- STRO $1.11
- SQNS $2.11
- Average True Range (ATR)
- STRO 0.18
- SQNS 0.18
- MACD
- STRO 0.02
- SQNS -0.04
- Stochastic Oscillator
- STRO 41.53
- SQNS 21.69
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.